{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T21:06:16Z","timestamp":1793480776447,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.tox.2021.152882","type":"journal-article","created":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T11:21:04Z","timestamp":1627903264000},"page":"152882","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["Oxaliplatin-induced hepatic sinusoidal obstruction syndrome"],"prefix":"10.1016","volume":"460","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7968-6003","authenticated-orcid":false,"given":"Chen","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuhua","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2021.152882_bib0005","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1200\/JCO.2006.05.8156","article-title":"Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases","volume":"24","author":"Aloia","year":"2006","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.tox.2021.152882_bib0010","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1200\/JCO.2008.20.6771","article-title":"Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial","volume":"27","author":"Andre","year":"2009","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.tox.2021.152882_bib0015","first-page":"1953","article-title":"Bevacizumab Improves Splenomegaly and Decreases Production of Hyaluronic Acid After L-OHP Based Chemotherapy","volume":"34","author":"Arakawa","year":"2014","journal-title":"Anticancer Res."},{"key":"10.1016\/j.tox.2021.152882_bib0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1179\/1973947814Y.0000000204","article-title":"Oxaliplatin-induced hypersensitivity reaction: underlying mechanisms and management","volume":"27","author":"Aroldi","year":"2015","journal-title":"J Chemother."},{"key":"10.1016\/j.tox.2021.152882_bib0025","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.surg.2008.12.002","article-title":"Risk factors for chemotherapy-associated liver injuries: a multivariate analysis of a group of 146 patients with colorectal metastases","volume":"145","author":"Brouquet","year":"2009","journal-title":"Surgery"},{"key":"10.1016\/j.tox.2021.152882_bib0030","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ejrad.2017.06.025","article-title":"Diagnostic performance of contrast-enhanced CT-scan in sinusoidal obstruction syndrome induced by chemotherapy of colorectal liver metastases: Radio-pathological correlation","volume":"94","author":"Cayet","year":"2017","journal-title":"Eur J Radiol."},{"key":"10.1016\/j.tox.2021.152882_bib0035","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.ejso.2017.05.008","article-title":"Hepatotoxicity following systemic therapy for colorectal liver metastases and the impact of chemotherapy-associated liver injury on outcomes after curative liver resection","volume":"43","author":"Duwe","year":"2017","journal-title":"Eur J Surg Oncol."},{"key":"10.1016\/j.tox.2021.152882_bib0040","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2147\/TCRM.S150968","article-title":"Increase in spleen volume as a predictor of oxaliplatin toxicity","volume":"14","author":"El","year":"2018","journal-title":"Ther Clin Risk Manag."},{"key":"10.1016\/j.tox.2021.152882_bib0045","doi-asserted-by":"crossref","first-page":"509","DOI":"10.4103\/0973-1482.154056","article-title":"Oxaliplatin-induced acute thrombocytopenia","volume":"12","author":"Erdem","year":"2016","journal-title":"J Cancer Res Ther."},{"key":"10.1016\/j.tox.2021.152882_bib0050","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jceh.2014.10.002","article-title":"Sinusoidal obstruction syndrome (hepatic veno-occlusive disease)","volume":"4","author":"Fan","year":"2014","journal-title":"J Clin Exp Hepatol."},{"key":"10.1016\/j.tox.2021.152882_bib0055","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.bbrc.2005.05.132","article-title":"Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy","volume":"333","author":"Ferrara","year":"2005","journal-title":"Biochem Biophys Res Commun."},{"key":"10.1016\/j.tox.2021.152882_bib0060","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1517\/14712598.2012.657623","article-title":"Update on the use of defibrotide","volume":"12","author":"Guglielmelli","year":"2012","journal-title":"Expert Opin Biol Th."},{"key":"10.1016\/j.tox.2021.152882_bib0065","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1148\/radiol.2015141749","article-title":"Hepatic Parenchymal Heterogeneity on Contrast-enhanced CT Scans Following Oxaliplatin-based Chemotherapy: Natural History and Association with Clinical Evidence of Sinusoidal Obstruction Syndrome","volume":"276","author":"Han","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.tox.2021.152882_bib0070","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.3892\/mmr.2017.6407","article-title":"Extravasated platelet aggregation in the livers of rats with druginduced hepatic sinusoidal obstruction syndrome","volume":"15","author":"Hirata","year":"2017","journal-title":"Mol Med Rep."},{"key":"10.1016\/j.tox.2021.152882_bib0075","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00423-015-1352-5","article-title":"Effects of oxaliplatin-based chemotherapy on liver function--an analysis of impact and functional recovery using the LiMAx test","volume":"401","author":"Jara","year":"2016","journal-title":"Langenbecks Arch Surg."},{"key":"10.1016\/j.tox.2021.152882_bib0080","doi-asserted-by":"crossref","first-page":"e198099","DOI":"10.1371\/journal.pone.0198099","article-title":"Interrogation of transcriptomic changes associated with drug-induced hepatic sinusoidal dilatation in colorectal cancer","volume":"13","author":"Jarzabek","year":"2018","journal-title":"PLOS ONE"},{"key":"10.1016\/j.tox.2021.152882_bib0085","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.ejso.2008.01.001","article-title":"Patterns of hepatotoxicity after chemotherapy for colorectal cancer liver metastases","volume":"34","author":"Kandutsch","year":"2008","journal-title":"EUR J SURG ONCOL."},{"key":"10.1016\/j.tox.2021.152882_bib0090","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27269","article-title":"Defibrotide for the treatment of hepatic veno-occlusive disease\/sinusoidal obstruction syndrome following nontransplant-associated chemotherapy: final results from a post hoc analysis of data from an expanded-access program","volume":"65","author":"Kernan","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.tox.2021.152882_bib0095","doi-asserted-by":"crossref","first-page":"990","DOI":"10.4143\/crt.2015.296","article-title":"Splenomegaly and Its Associations with Genetic Polymorphisms and Treatment Outcome in Colorectal Cancer Patients Treated with Adjuvant FOLFOX","volume":"48","author":"Kim","year":"2016","journal-title":"CANCER RES TREAT."},{"key":"10.1016\/j.tox.2021.152882_bib0100","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/ccr3.1935","article-title":"Peripheral hepatic sinusoidal obstruction syndrome due to oxaliplatin-based chemotherapy","volume":"7","author":"Kobayashi","year":"2019","journal-title":"CLIN CASE REP."},{"key":"10.1016\/j.tox.2021.152882_bib0105","series-title":"Clinical and Research Information on Drug-Induced Liver Injury [Internet]","author":"LiverTox","year":"2020"},{"key":"10.1016\/j.tox.2021.152882_bib0110","first-page":"2398","article-title":"Oxaliplatin aggravates hepatic oxidative stress, inflammation and fibrosis in a nonalcoholic fatty liver disease mouse model","volume":"43","author":"Lu","year":"2019","journal-title":"Int J Mol Med."},{"key":"10.1016\/j.tox.2021.152882_bib0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186250","article-title":"Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: phenotypic and genotypic insights","volume":"12","author":"Marmiroli","year":"2017","journal-title":"Plos One"},{"key":"10.1016\/j.tox.2021.152882_bib0120","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.ejso.2007.09.007","article-title":"Effect of preoperative chemotherapy on liver resection for colorectal liver metastases","volume":"34","author":"Mehta","year":"2008","journal-title":"Eur J Surg Oncol."},{"key":"10.1016\/j.tox.2021.152882_bib0125","doi-asserted-by":"crossref","first-page":"34857","DOI":"10.18632\/oncotarget.26207","article-title":"Bevacizumab as a chemoprotectant: reducing oxaliplatin induced hepatic sinusoidal injury","volume":"9","author":"Mizrahi","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.tox.2021.152882_bib0130","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/SLA.0b013e31815774de","article-title":"Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy","volume":"247","author":"Nakano","year":"2008","journal-title":"Ann Surg."},{"key":"10.1016\/j.tox.2021.152882_bib0135","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/1751-2980.12177","article-title":"Histological features and severity of oxaliplatin-induced liver injury and clinical associations","volume":"15","author":"Nalbantoglu","year":"2014","journal-title":"J Dig Dis."},{"key":"10.1016\/j.tox.2021.152882_bib0140","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4132\/KoreanJPathol.2012.46.1.22","article-title":"Chemotherapy-associated hepatopathy in korean colorectal cancer liver metastasis patients: oxaliplatin-based chemotherapy and sinusoidal injury","volume":"46","author":"Nam","year":"2012","journal-title":"Korean J Pathol."},{"key":"10.1016\/j.tox.2021.152882_bib0145","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/jnci\/djx288","article-title":"The Addition of Bevacizumab to Oxaliplatin-Based Chemotherapy: Impact Upon Hepatic Sinusoidal Injury and Thrombocytopenia","volume":"110","author":"Overman","year":"2018","journal-title":"JNCI-J Natl Cancer I."},{"key":"10.1016\/j.tox.2021.152882_bib0150","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1200\/JCO.2009.27.5701","article-title":"Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury","volume":"28","author":"Overman","year":"2010","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.tox.2021.152882_bib0155","doi-asserted-by":"crossref","first-page":"e2454","DOI":"10.1097\/MD.0000000000002454","article-title":"Changes in Noninvasive Liver Fibrosis Indices and Spleen Size During Chemotherapy: Potential Markers for Oxaliplatin-Induced Sinusoidal Obstruction Syndrome","volume":"95","author":"Park","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.tox.2021.152882_bib0160","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jhep.2013.04.014","article-title":"Pathogenesis of FOLFOX induced sinusoidal obstruction syndrome in a murine chemotherapy model","volume":"59","author":"Robinson","year":"2013","journal-title":"J Hepatol."},{"key":"10.1016\/j.tox.2021.152882_bib0165","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/annonc\/mdh095","article-title":"Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer","volume":"15","author":"Rubbia-Brandt","year":"2004","journal-title":"Ann Oncol."},{"key":"10.1016\/j.tox.2021.152882_bib0170","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1365-2559.2010.03511.x","article-title":"Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis","volume":"56","author":"Rubbia-Brandt","year":"2010","journal-title":"Histopathology"},{"key":"10.1016\/j.tox.2021.152882_bib0175","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1158\/1535-7163.MCT-10-1072","article-title":"Gene expression profiling provides insights into pathways of oxaliplatin-related sinusoidal obstruction syndrome in humans","volume":"10","author":"Rubbia-Brandt","year":"2011","journal-title":"Mol Cancer Ther."},{"key":"10.1016\/j.tox.2021.152882_bib0180","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijsu.2016.05.065","article-title":"Preoperative assessment of chemotherapeutic associated liver injury based on indocyanine green retention test","volume":"31","author":"Russolillo","year":"2016","journal-title":"Int J Surg."},{"key":"10.1016\/j.tox.2021.152882_bib0185","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1016\/j.ajpath.2016.03.010","article-title":"Delta-Like Ligand 4 Modulates Liver Damage by Down-Regulating Chemokine Expression","volume":"186","author":"Shen","year":"2016","journal-title":"Am J Pathol."},{"key":"10.1016\/j.tox.2021.152882_bib0190","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1038\/sj.onc.1206933","article-title":"Cisplatin: mode of cytotoxic action and molecular basis of resistance","volume":"22","author":"Siddik","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.tox.2021.152882_bib0195","first-page":"665","article-title":"Oxaliplatin: The first DACH platinum in clinical practice","volume":"84","author":"Soulie","year":"1997","journal-title":"Breast Cancer"},{"key":"10.1016\/j.tox.2021.152882_bib0200","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.arcmed.2015.10.002","article-title":"Oxaliplatin-induced Oxidative Stress Provokes Toxicity in Isolated Rat Liver Mitochondria","volume":"46","author":"Tabassum","year":"2015","journal-title":"Arch Med Res."},{"key":"10.1016\/j.tox.2021.152882_bib0205","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3892\/mco.2015.512","article-title":"Oxaliplatin-based chemotherapy induces extravasated platelet aggregation in the liver","volume":"3","author":"Tajima","year":"2015","journal-title":"Mol Clin Oncol."},{"key":"10.1016\/j.tox.2021.152882_bib0210","first-page":"378","article-title":"Sinusoidal obstruction syndrome","volume":"40","author":"Valla","year":"2016","journal-title":"Clin Res Hepatol Gas."},{"key":"10.1016\/j.tox.2021.152882_bib0215","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.suronc.2016.05.030","article-title":"The influence of chemotherapy-associated sinusoidal dilatation on short-term outcome after partial hepatectomy for colorectal liver metastases: a systematic review with meta-analysis","volume":"25","author":"van Mierlo","year":"2016","journal-title":"Surg Oncol."},{"key":"10.1016\/j.tox.2021.152882_bib0220","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1365-2559.2012.04208.x","article-title":"Hepatic sinusoidal obstruction syndrome (SOS) reduces the effect of oxaliplatin in colorectal liver metastases","volume":"61","author":"Vreuls","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.tox.2021.152882_bib0225","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrd1691","article-title":"Cellular processing of platinum anticancer drugs","volume":"4","author":"Wang","year":"2005","journal-title":"Nat Rev Drug Discov."},{"key":"10.1016\/j.tox.2021.152882_bib0230","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1136\/gutjnl-2016-313392","article-title":"The HLF\/IL-6\/STAT3 feedforward circuit drives hepatic stellate cell activation to promote liver fibrosis","volume":"67","author":"Xiang","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.tox.2021.152882_bib0235","doi-asserted-by":"crossref","first-page":"9419","DOI":"10.1002\/jcb.27259","article-title":"IL-6\/STAT3 pathway intermediates M1\/M2 macrophage polarization during the development of hepatocellular carcinoma","volume":"119","author":"Yin","year":"2018","journal-title":"J Cell Biochem."},{"key":"10.1016\/j.tox.2021.152882_bib0240","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/bjs.10572","article-title":"Systematic review of the influence of chemotherapy-associated liver injury on outcome after partial hepatectomy for colorectal liver metastases","volume":"104","author":"Zhao","year":"2017","journal-title":"Br J Surg."},{"key":"10.1016\/j.tox.2021.152882_bib0245","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/jgh.14612","article-title":"Expert consensus on the clinical management of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome","volume":"34","author":"Zhuge","year":"2019","journal-title":"J Gastroenterol Hepatol."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X21002055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X21002055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:47:44Z","timestamp":1759535264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X21002055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":49,"alternative-id":["S0300483X21002055"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2021.152882","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oxaliplatin-induced hepatic sinusoidal obstruction syndrome","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2021.152882","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152882"}}